Compare BFC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BFC | YDES |
|---|---|---|
| Founded | 1894 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 894.2M |
| IPO Year | 2018 | N/A |
| Metric | BFC | YDES |
|---|---|---|
| Price | $134.18 | $8.14 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $150.00 | N/A |
| AVG Volume (30 Days) | ★ 79.5K | 13.2K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | ★ 11.23 | N/A |
| EPS | ★ 7.23 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $58.67 | N/A |
| Revenue Next Year | $2.01 | N/A |
| P/E Ratio | $18.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $93.00 | $7.90 |
| 52 Week High | $153.00 | $25.00 |
| Indicator | BFC | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 32.66 |
| Support Level | $118.71 | N/A |
| Resistance Level | $140.92 | $9.46 |
| Average True Range (ATR) | 4.16 | 0.57 |
| MACD | -1.12 | 0.03 |
| Stochastic Oscillator | 28.13 | 17.15 |
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.